Multiple sclerosis (MS) is the most common disease of the brain and spinal cord in young people. European doctors started talking about a new epidemic: multiple sclerosis came out on top among the diseases leading to disability of young people. In the course of the disease, an autoimmune inflammation occurs, which causes damage to the myelin layer surrounding the nerve cells. Damage occurs in numerous foci of the brain and spinal cord. Currently, there are more than 2 million patients with MS in the world [1].
Multiple Sclerosis (MS) is an autoimmune disease that leads to a demyelination process. The clinical picture of the disease is complex, and an important part of it are the non-motor symptoms, such as: dysphagia, sleep disorders, fatigue and pain, and the bladder function disorders. Some questionnaires were used to assess some of the dysfunctions listed above.
The treatment of non-motor symptoms in patients with multiple sclerosis is based on the use of a various forms of therapy: pharmacotherapy, physiotherapy and surgical treatment. The aim of these is to improve the quality of life of the patient.
The aim of this work is to present non-inguinal disorders occurring in patients with MS. The bibliographic databases were searched: PubMed, MedLine, Polish Medical and others. Bibliography. Articles in Polish and English were used.

multiple sclerosis; non-motor symptoms; dysphagia; fatigue in MS

Pazhigova Z.B., Karpov S.M., Shevchenko P.P., Burnusus N.I. RASPROSTRANENNOST' RASSEYANNOGO SKLEROZA V MIRE (OBZORNAYA STAT'YA) // Mezhdunarodnyy zhurnal eksperimental'nogo obrazovaniya. – 2014. – № 1-2. – S. 78-82; (in Russian)

Mazur R: Neurologia kliniczna. Wyd. Via Medica, Gdańsk 2007: 271 - 280.

Lindsay W.K, Bone I, Fuller G: Neurologia i neurochirurgia. Wyd. Edra Urban&Partner, Wrocław 2013: 520 - 528.

Bonek R, Maciejek Z: Natural history of multiple sclerosis. Aktualn.Neurol. 2009; 9 (2): 116 - 125.

Bartosik-Psujek H: Current therapy of multiple sclerosis. Aktualn. Neurol. 2009; 9 (2): 126 - 131.

Podemski R: Kompendium neurologii. Wyd. Via Medica, Gdańsk 2008: 299 - 321.

Mechelli R. et al. Multiple sclerosis etiology: beyond genes and environment // Expert review of clinical immunology. — 2010. — Т. 6. — №. 3. — С. 481–490.

Majchrzycki M, Łańczak-Trzaskowska M, Gajewska E: Dysfunkcje narządów ruchu. Diagnostyka i usprawnianie pacjentów z dysfunkcjami narządów ruchu tom 4. Wydawnictwo Naukowe Uniwersytetu Medycznego w Poznaniu, Poznań 2013: 102 - 111.

Alali D, Ballard K, Bogaardt H: Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review. Dysphagia 2016; 31: 610 – 618.

Brola W, Kasprzyk M, Fudala M, Opara J: Palliative care for patients with multiple sclerosis. Medycyna Paliatywna 2013; 5 (2): 41 - 47.

Guan X, Wang H, Huang H, Meng L: Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis. Neurol. Sci. 2015; 36: 671 – 681.

Przeździęk M: Usprawnianie mowy w SM. Zestaw ćwiczeń logopedycznych dla osób chorych na stwardnienie rozsiane. Wyd. Polskie Towarzystwo Stwardnienia Rozsianego Oddział Warszawski, Warszawa 2011: 30 - 34.

Alali D, Ballard K, Bogaard H: The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires. Multiple Sclerosis and Related Disorders 2018; 25: 227–231.

Czernuszenko A: Diagnosis and treatment of neurogenic dysphagia. Otorynolaryngologia 2016, 15 (2): 68 - 74.

Tenekeci E, Kara B, Cetiz A, Demirkaya S, Demir N, Acikel C: Validity and Reliability of the Turkish Version of the Questionnaire for the Assessment of Dysphagia in Multiple Sclerosi. Arch. Neuropsychiatry 2018; 55: 243 − 247.

Jamróz B, Milewska M, Chmielewska J, Grabarczyk E, Dąbrowska M, Niemczyk K: Evaluation of dysphagia as a cause of chronic cough. Otorynolaryngologia 2016; 15 (2): 94 - 98.

Wiskirska-Woźnica B: Introduction of dysphagia as an interdisciplinary problem. Otorynolaryngologia 2016, 15 (2): 59 - 62.

Van den Akker L. E., Beckerman H., Collette H. E., et al. Effectiveness of cognitive behavioural therapy for the treatment of fatigue with multiple sclerosis: a systematic review and meta-analysis. Journal of Psychosomatic Research. 2016; 90: 33 – 42.

Kobelt G., Thompson A., Berg J., Gannedahl M., Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal. 2017; 23 (8): 1123–1136.

Kos D , Kerckhofs E., Nagels G , D'Hooghe MB , Ilsbroukx S.: Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair. 2008;

(1):91-100.

Yang TT , Wang L , Deng XY , Yu G : Leczenie farmakologiczne zmęczenia u pacjentów ze stwardnieniem rozsianym: Przegląd systematyczny i metaanaliza. J Neurol Sci. 2017; 380: 256-261

Khan F, Amatya B, Galea M.: Management of fatigue in persons with multiple sclerosis. Front Neurol. 2014;5:177

Kobelt G., Thompson A., Berg J., Gannedahl M., Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal. 2017;23(8):1123–1136

Najafi MR , Toghianifar N , Etemadifar M , Haghighi S , Maghzi AH , Akbari M.: Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study. J Res Med Sci. 2013;18:71-3

Buysse, D.J., Reynolds III, C.F., Monk, T.H., Berman, S.R., Kupfer, D.J.: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Journal of Psychiatric Research, 1989;28(2):193-213.

Malec-Milewska, Małgorzata.: Ból u chorych na stwardnienie rozsiane.Palliative Medicine in Practice 8.1 (2014): 29-40.

Svendsen K.B., Jensen T.S., Overvad K., Hansen H.J., Koch-Henriksen N., Bach F.W.: Pain in patients with multiple sclerosis: a population-based study. Arch. Neurol. 2003; 60: 1089–1094.

O’Connor A.B., Schwid S.R., Herrmann D.N. i wsp.: Pain associatedwith multiple sclerosis systematic reviev and proposedclassification. Pain 2008; 137: 96–111.

Kalia L.V., O, Connor P.W.: Severityof chronic pain and its relationship to quality for life in multiple sclerosis. Mult. Scler. 2005; 11: 322–327

Malec-Milewska M., Dobrogowski J., Sękowska A.: Inwazyjne metody leczenia bólu u chorego na nowotwór., Chory na nowotwór. Kompendium leczenia bólu. Malec-Milewska M., Krajnik M., Wordliczek J. (red.). Medical Educaton. Warszawa 2013: 309–329.

Malec-Milewska M. Powierzchniowe lub przezskórne podawanie leków w terapii bólu. W: Chory na nowotwór. Kompendium leczenia bólu. Malec-Milewska M., Krajnik M., Wordliczek J. Medical Educaton. Warszawa 2013: 157–177. ,

Bartosik-Psujek H., Malec-Milewska M., Berkowicz T., Jedrzejewski B., Radziszewski P., Selmaj K.: Nowoczesne leczenie objawowe w stwardnieniu rozsianym. Polski Przegląd Neurochirurgiczny 2013; 4 (9): 160–171

Selmaj, Krzysztof.: Stwardnienie rozsiane-kryteria diagnostyczne i naturalny przebieg choroby. Polski Przegląd Neurologiczny 1.3 (2005): 99-105.

Pittock S.J., McClelland R.J., Mayr W.T. i wsp. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann. Neurol. 2004; 56 (2): 303–306.

Brola, Waldemar, et al. "Opieka paliatywna nad pacjentami ze stwardnieniem rozsianym." Palliative Medicine/Medycyna Paliatywna 2 (2013)., 41-47

Samkoff L.M., Goodman A.D. Symptomatic management in multiple sclerosis. Neurol Clin 2011; 29: 449-463. 27.

Kesselring J., Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005; 4: 643-652.

de Abreu Pereira, Carla Maria, Mariane Castiglione, and Karina Tamy Kasawara. "Effects of physiotherapy treatment for urinary incontinence in patient with multiple sclerosis." Journal of physical therapy science 29.7 (2017): 1259-1263

Tarameshlu M, Azimi A, Ghelichi L, Ansari N: Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Med J Islam Repub Iran. 2017; 31: 133.

Pajouha S, Moradia N, Yazdia M, Latifib S, Mehravara M, Majdinasaba N, Olapourc A, Soltania M, Khanchezara F: Diagnostic evaluation of dysphagia in multiple sclerosis patients using a Persian version of DYMUS questionnaire. Multiple Sclerosis and Related Disorders 2017; 17: 240–243.

Bøe Lunde HM1, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L: Poor sleep in patients with multiple sclerosis. PLoS One. 2012;7(11)

Tabrizi FM, Radfar M.: Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis. Int J MS Care. 2015;17(6):268–274.

Labuz-Roszak B1, Kubicka-Bączyk K, Pierzchała K, Machowska-Majchrzak A, Skrzypek M.: Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Neurol Neurochir Pol. 2012;46(4):309-17

Rog DJ, Nurmikko T.J, Friede T. i wsp.: Randomized, controlled trial of cannabis in central pain in multiple sclerosis. Neurology 2005; 65: 812–819.

Osborne T.L, Jensen M.P, Ehde D.M., Hanley M.A., Kraft G.: Psychosocial factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain. Pain 2007; 127: 52–62.

Berkowicz, T, Selmaj K.: Leczenie objawowe stwardnienia rozsianego. Polski Przegląd Neurologiczny, 2005; 1(3), 124-129.